Related Experiment Video
Updated: Aug 11, 2026
06:02
An Approach to Study Shape-Dependent Transcriptomics at a Single Cell Level
Published on: November 2, 2020
Recent developments in proteomics: implications for the study of cardiac hypertrophy and failure
Matthijs J Faber1, Giulio Agnetti, Karel Bezstarosti
1Department of Pediatrics, Division of Pediatric Cardiology, Cardiovascular Research School COEUR, Erasmus MC, Sophia Children's Hospital, Rotterdam, The Netherlands.
Cell Biochemistry and Biophysics
|February 4, 2006
Summary
Proteomics offers a powerful approach to understanding heart failure by identifying key proteins involved in cardiac dysfunction. This technology enables comprehensive protein analysis for disease insight and therapeutic development.
Area of Science:
- Cardiovascular Biology
- Proteomics
- Molecular Medicine
Background:
- Understanding heart failure pathophysiology requires molecular insights beyond genomics.
- Proteins, their expression, modifications, and functions are crucial for cardiac (mal)adaptive growth, fibrosis, and dysfunction.
- Genomic data alone is insufficient to fully elucidate cardiovascular disease etiology.
Purpose of the Study:
- To review the current status and future perspectives of proteomics in heart failure research.
- To highlight the utility of proteomics in identifying protein alterations related to heart disease.
- To present examples of proteomic profiling in relevant heart failure models.
Main Methods:
- Review of existing proteomics methodologies and their limitations.
- Global protein profiling of pressure-overloaded rat right ventricles.
- Analysis of endothelin-1-stimulated neonatal rat cardiac myocytes.
- Discussion of advances in protein separation, mass spectrometry, and bioinformatics.
Main Results:
- Proteomics enables mapping of the heart's proteome under various conditions.
- Differential protein analysis can identify alterations linked to heart disease etiology, progression, and treatment response.
- Specific examples of proteomic data from experimental models are provided.
Conclusions:
- Proteomics provides a protein-centric perspective crucial for understanding heart failure.
- This technology facilitates the identification of disease biomarkers and therapeutic targets.
- Continued advances in proteomic technologies will further enhance heart failure research.
Related Concept Videos
01:29Cardiomyopathy III: Hypertrophic Cardiomyopathy
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
01:29Heart Failure II: Pathophysiology
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
01:26Cellular Adaptation II: Hypertrophy
Hypertrophy is the increase in the size of individual cells, resulting in the enlargement of a tissue or organ. Unlike hyperplasia, which involves an increase in cell number, hypertrophy is characterized by an increase in cell volume. This process often occurs in response to higher functional demand or hormonal stimulation, leading to the production of more structural proteins and organelles, thereby enhancing the cells' work capacity.There are two primary types of hypertrophy: physiological...
01:19Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
01:20Blood Studies for Cardiovascular System I: Cardiac Biomarkers
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...